【序号】:1 【作者】:Toguchi H1, Ogawa Y, Okada H, Yamamoto M. 【题名】:. 【期刊】:Yakugaku Zasshi. 【年、卷、期、起止页码】:1991 Aug;111(8):397-409. 【全文链接】:https://www.ncbi.nlm.nih.gov/pubmed/1795229 【序号】:2 【作者】:Ogawa Y, Okada H, Yamamoto M, Shimamoto T. 【题名】:In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic/glycolic) acids and in vivo degradation of these polymers. 【期刊】:Chem Pharm Bull (Tokyo). 【年、卷、期、起止页码】:1988 Jul;36(7):2576-81. 【全文链接】:https://www.ncbi.nlm.nih.gov/pubmed/3149211 【序号】:3 【作者】:Asano M1, Fukuzaki H, Yoshida M, Kumakura M, Mashimo T, Yuasa H, Imai K, Yamanaka H. 【题名】:In vivo characteristics of low molecular weight copoly (D,L-lactic acid) formulations with controlled release of LH-RH agonist. 【期刊】:Biomaterials. 【年、卷、期、起止页码】:1989 Oct;10(8):569-73. 【全文链接】:https://www.ncbi.nlm.nih.gov/pubmed/2513891 【序号】:4 【作者】:Takada S1, Ogawa Y. 【题名】:. 【期刊】:Nihon Rinsho. 【年、卷、期、起止页码】:1998 Mar;56(3):675-9. 【全文链接】:https://www.ncbi.nlm.nih.gov/pubmed/9549355 【序号】:5 【作者】:Toguchi H1. 【题名】:Formulation study of leuprorelin acetate to improve clinical performance. 【期刊】:Clin Ther. 【年、卷、期、起止页码】:1992;14 Suppl A:121-30. 【全文链接】:https://www.ncbi.nlm.nih.gov/pubmed/1606592